Laboratory chemicals market seen reaching $48.31 billion by 2035

Market Research Future projects the global laboratory chemicals market will grow from $32.28 billion in 2026 to $48.31 billion by 2035, driven by pharmaceutical R&D, lab automation and tighter regulatory quality standards. The report points to the U.S., Europe and Asia-Pacific as major demand centers as buyers shift toward higher-spec reagents and certified reference materials.

Why it matters: - Laboratory chemicals are becoming a core input for drug discovery, clinical testing, genomics and quality-control labs. - The market is moving from commodity purchasing toward higher-value analytical-grade and certified-reference products. - The shift affects research budgets, procurement systems and lab workflow design across academia, healthcare and industry.

What happened: - Market Research Future said the global laboratory chemicals market is projected to rise from USD 32.28 billion in 2026 to USD 48.31 billion by 2035. - The forecast implies a 4.58% CAGR for 2026-2035. - The market base was estimated at USD 30.87 billion in 2025. - The company published the projection on July 14, 2026. - A free sample is available from the report page.

The details: - Pharmaceutical R&D spending is a major demand driver because reagent purchases typically rise with drug-development activity. - Pharmaceutical companies invested USD 215 billion in R&D in 2024, according to EFPIA and PhRMA disclosures. - Reagent procurement typically accounts for 3% to 5% of total R&D budgets. - Laboratory automation is changing purchasing patterns by increasing demand for pre-formatted reagent cartridges and certified liquid standards. - The global laboratory automation market exceeded USD 6.2 billion in 2024. - Automated-format chemicals carry a 20% to 35% price premium over bulk equivalents. - Regulatory rules are also lifting demand for higher-spec products. - The European Chemicals Agency updated 23 substance restriction entries under REACH Annex XVII in 2023-2024. - The U.S. EPA finalized risk evaluations for five high-priority chemicals under TSCA. - The International Council of Chemical Associations valued the compliance-driven shift at USD 4.6 billion in incremental spending through 2028. - Government and institutional funding is supporting lab procurement. - The U.S. National Institutes of Health directed about USD 37 billion in extramural research funding in 2024. - Horizon Europe channels €95.5 billion into research through 2027. - China’s Ministry of Science and Technology allocated CNY 395 billion, or about USD 55 billion, to basic-research grants in its 2024 fiscal plan. - India’s Department of Science and Technology increased laboratory infrastructure budgets by 18% year over year.

Between the lines: - The report frames laboratory chemicals as a structurally growing market, not a cyclical one tied to broad healthcare spending. - Higher automation and compliance requirements favor suppliers that can sell ready-to-use, traceable and premium-grade products. - The market also appears to be consolidating around large integrated suppliers and specialized niche producers. - The top five companies account for an estimated 38% to 44% of global revenue. - Merck KGaA opened a USD 300 million reagent manufacturing facility in Carlsbad, California, in March 2024. - Thermo Fisher Scientific, Avantor, Honeywell, BD and Bio-Rad Laboratories remain major players in the market. - The report says future growth will be reinforced by precision-medicine workflows and diagnostic-therapeutic pairing.

What’s next: - Biochemistry remains the largest type segment with about 29.3% revenue share in 2025. - Healthcare/pharmaceutical reagents are the fastest-growing type segment at 5.35% CAGR through 2035. - Academia and educational use is the largest application segment with about 33.1% revenue share in 2025. - Healthcare/pharmaceutical applications are the fastest-growing application segment at 5.0% CAGR through 2035. - Pharmaceutical companies are the largest end-user segment with about 31.9% share in 2025. - North America leads the market with about 31.9% share in 2025. - Asia-Pacific is the fastest-growing region at 5.03% CAGR through 2035. - The report says laboratory decision-support tools and biomarker-driven therapy workflows could reshape purchasing patterns by 2030.

The bottom line: - Laboratory chemicals are set for steady growth through 2035 as R&D spending, automation and regulation push labs toward higher-value products.